Protein family
The protein has not catalytic activity
Protein sequence
Protein function
Catalytic activity
PDB | Resolution (Å) | PDB name |
---|---|---|
1G3J | 2.1 | CRYSTAL STRUCTURE OF THE XTCF3-CBD/BETA-CATENIN ARMADILLO REPEAT COMPLEX |
1JDH | 1.9 | CRYSTAL STRUCTURE OF BETA-CATENIN AND HTCF-4 |
1JPW | 2.5 | Crystal Structure of a Human Tcf-4 / beta-Catenin Complex |
1LUJ | 2.5 | Crystal Structure of the Beta-catenin/ICAT Complex |
1P22 | 2.95 | Structure of a beta-TrCP1-Skp1-beta-catenin complex: destruction motif binding and lysine specificity on the SCFbeta-TrCP1 ubiquitin ligase |
1QZ7 | 2.2 | Beta-catenin binding domain of Axin in complex with beta-catenin |
1T08 | 2.1 | Crystal structure of beta-catenin/ICAT helical domain/unphosphorylated APC R3 |
1TH1 | 2.5 | Beta-catenin in complex with a phosphorylated APC 20aa repeat fragment |
2G57 | Structure of the Phosphorylation Motif of the oncogenic Protein beta-Catenin Recognized By a Selective Monoclonal Antibody | |
2GL7 | 2.6 | Crystal Structure of a beta-catenin/BCL9/Tcf4 complex |
2Z6H | 2.2 | Crystal Structure of Beta-Catenin Armadillo Repeat Region and Its C-Terminal domain |
3DIW | 2.1 | c-terminal beta-catenin bound TIP-1 structure |
3FQN | 1.65 | Phosphorylation of self-peptides alters Human Leukocyte Antigen Class I-restricted antigen presentation and generates tumor specific epitopes |
3FQR | 1.7 | Phosphorylation of self-peptides alters Human Leukocyte Antigen Class I-restricted antigen presentation and generates tumor specific epitopes |
3SL9 | 2.2 | X-ray structure of Beta catenin in complex with Bcl9 |
3SLA | 2.5 | X-ray structure of first four repeats of human beta-catenin |
3TX7 | 2.76 | Crystal structure of LRH-1/beta-catenin complex |
4DJS | 3.029 | Structure of beta-catenin in complex with a stapled peptide inhibitor |
6M90 | 2.05 | Monophosphorylated pSer33 b-Catenin peptide, b-TrCP/Skp1, NRX-2776 ternary complex |
6M91 | 2.4 | Monophosphorylated pSer33 b-Catenin peptide, b-TrCP/Skp1, NRX-103094 ternary complex |
6M92 | 2.35 | Monophosphorylated pSer33 b-Catenin peptide, b-TrCP/Skp1, NRX-2663 ternary complex |
6M93 | 2.5 | Monophosphorylated pSer33 b-Catenin peptide, b-TrCP/Skp1, NRX-1933 ternary complex |
6M94 | 2.7 | Monophosphorylated pSer33 b-Catenin peptide bound to b-TrCP/Skp1 Complex |
6O9B | 2.2 | Crystal structure of HLA-A3*01 in complex with a wild-type beta-catenin peptide |
6O9C | 2.45 | Crystal structure of HLA-A3*01 in complex with a mutant beta-catenin peptide |
6WLX | 2.2 | PAK4 kinase domain in complex with beta-catenin Ser675 substrate peptide |
6WNX | 2.5 | FBXW11-SKP1 in complex with a pSer33/pSer37 Beta-Catenin peptide |
7AFW | 1.814 | Beta-Catenin in complex with compound 6 |
7AR4 | 2.6 | Crystal structure of beta-catenin in complex with cyclic peptide inhibitor |
7UWI | 2.32 | Structure of beta-catenin in complex with FP01567, a Helicon Polypeptide |
7UWO | 2.75 | Structure of beta-catenin in complex with FP05874, a Helicon Polypeptide |
GO ontology
|
GO term | GO description |
---|---|---|
Biological Process | GO:0072054 | renal outer medulla development |
Biological Process | GO:0031069 | hair follicle morphogenesis |
Biological Process | GO:0045944 | positive regulation of transcription by RNA polymerase II |
Biological Process | GO:0035115 | embryonic forelimb morphogenesis |
Biological Process | GO:2000288 | positive regulation of myoblast proliferation |
Biological Process | GO:0030539 | male genitalia development |
Biological Process | GO:0036023 | embryonic skeletal limb joint morphogenesis |
Biological Process | GO:0048599 | oocyte development |
Biological Process | GO:0001764 | neuron migration |
Biological Process | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process |
Biological Process | GO:0021854 | hypothalamus development |
Biological Process | GO:0009950 | dorsal/ventral axis specification |
Biological Process | GO:0000209 | protein polyubiquitination |
Biological Process | GO:0060441 | epithelial tube branching involved in lung morphogenesis |
Biological Process | GO:0032968 | positive regulation of transcription elongation by RNA polymerase II |
Biological Process | GO:0044334 | canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition |
Biological Process | GO:0019827 | stem cell population maintenance |
Biological Process | GO:0048664 | neuron fate determination |
Biological Process | GO:0060066 | oviduct development |
Biological Process | GO:0061198 | fungiform papilla formation |
Biological Process | GO:0070602 | regulation of centromeric sister chromatid cohesion |
Biological Process | GO:0035315 | hair cell differentiation |
Biological Process | GO:0050808 | synapse organization |
Biological Process | GO:0003266 | regulation of secondary heart field cardioblast proliferation |
Biological Process | GO:0031641 | regulation of myelination |
Biological Process | GO:0072497 | mesenchymal stem cell differentiation |
Biological Process | GO:0021819 | layer formation in cerebral cortex |
Biological Process | GO:0061324 | canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation |
Biological Process | GO:0060856 | establishment of blood-brain barrier |
Biological Process | GO:0035116 | embryonic hindlimb morphogenesis |
Biological Process | GO:0007268 | chemical synaptic transmission |
Biological Process | GO:0001658 | branching involved in ureteric bud morphogenesis |
Biological Process | GO:0034394 | protein localization to cell surface |
Biological Process | GO:0061549 | sympathetic ganglion development |
Biological Process | GO:0072089 | stem cell proliferation |
Biological Process | GO:0051091 | positive regulation of DNA-binding transcription factor activity |
Biological Process | GO:0031016 | pancreas development |
Biological Process | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway |
Biological Process | GO:2000008 | regulation of protein localization to cell surface |
Biological Process | GO:0060916 | mesenchymal cell proliferation involved in lung development |
Biological Process | GO:0030902 | hindbrain development |
Biological Process | GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process |
Biological Process | GO:0045976 | negative regulation of mitotic cell cycle, embryonic |
Biological Process | GO:0006366 | transcription by RNA polymerase II |
Biological Process | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation |
Biological Process | GO:0045597 | positive regulation of cell differentiation |
Biological Process | GO:0000904 | cell morphogenesis involved in differentiation |
Biological Process | GO:0009954 | proximal/distal pattern formation |
Biological Process | GO:0042475 | odontogenesis of dentin-containing tooth |
Biological Process | GO:0061550 | cranial ganglion development |
Biological Process | GO:0072182 | regulation of nephron tubule epithelial cell differentiation |
Biological Process | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis |
Biological Process | GO:0035112 | genitalia morphogenesis |
Biological Process | GO:0048617 | embryonic foregut morphogenesis |
Biological Process | GO:0002062 | chondrocyte differentiation |
Biological Process | GO:0007160 | cell-matrix adhesion |
Biological Process | GO:2001234 | negative regulation of apoptotic signaling pathway |
Biological Process | GO:0044338 | canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation |
Biological Process | GO:1990403 | embryonic brain development |
Biological Process | GO:1904954 | canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation |
Biological Process | GO:0022009 | central nervous system vasculogenesis |
Biological Process | GO:0071681 | cellular response to indole-3-methanol |
Biological Process | GO:0060440 | trachea formation |
Biological Process | GO:0051145 | smooth muscle cell differentiation |
Biological Process | GO:0036520 | astrocyte-dopaminergic neuron signaling |
Biological Process | GO:1904798 | positive regulation of core promoter binding |
Biological Process | GO:0060769 | positive regulation of epithelial cell proliferation involved in prostate gland development |
Biological Process | GO:0035995 | detection of muscle stretch |
Biological Process | GO:0001708 | cell fate specification |
Biological Process | GO:1904948 | midbrain dopaminergic neuron differentiation |
Biological Process | GO:0048145 | regulation of fibroblast proliferation |
Biological Process | GO:0010628 | positive regulation of gene expression |
Biological Process | GO:0032355 | response to estradiol |
Biological Process | GO:0051963 | regulation of synapse assembly |
Biological Process | GO:0001569 | branching involved in blood vessel morphogenesis |
Biological Process | GO:0061047 | positive regulation of branching involved in lung morphogenesis |
Biological Process | GO:0071363 | cellular response to growth factor stimulus |
Biological Process | GO:0043410 | positive regulation of MAPK cascade |
Biological Process | GO:0031396 | regulation of protein ubiquitination |
Biological Process | GO:0048469 | cell maturation |
Biological Process | GO:0002053 | positive regulation of mesenchymal cell proliferation |
Biological Process | GO:0060487 | lung epithelial cell differentiation |
Biological Process | GO:0072079 | nephron tubule formation |
Biological Process | GO:1903204 | negative regulation of oxidative stress-induced neuron death |
Biological Process | GO:0016525 | negative regulation of angiogenesis |
Biological Process | GO:0000122 | negative regulation of transcription by RNA polymerase II |
Biological Process | GO:0090279 | regulation of calcium ion import |
Biological Process | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling |
Biological Process | GO:0008285 | negative regulation of cell population proliferation |
Biological Process | GO:0048538 | thymus development |
Biological Process | GO:0045765 | regulation of angiogenesis |
Biological Process | GO:0051973 | positive regulation of telomerase activity |
Biological Process | GO:0090425 | acinar cell differentiation |
Biological Process | GO:0007155 | cell adhesion |
Biological Process | GO:0051884 | regulation of timing of anagen |
Biological Process | GO:0060070 | canonical Wnt signaling pathway |
Biological Process | GO:0043065 | positive regulation of apoptotic process |
Biological Process | GO:0048660 | regulation of smooth muscle cell proliferation |
Biological Process | GO:0050767 | regulation of neurogenesis |
Biological Process | GO:0045669 | positive regulation of osteoblast differentiation |
Biological Process | GO:0033077 | T cell differentiation in thymus |
Biological Process | GO:0098609 | cell-cell adhesion |
Biological Process | GO:0009410 | response to xenobiotic stimulus |
Biological Process | GO:0042733 | embryonic digit morphogenesis |
Biological Process | GO:0007403 | glial cell fate determination |
Biological Process | GO:0051571 | positive regulation of histone H3-K4 methylation |
Biological Process | GO:0010909 | positive regulation of heparan sulfate proteoglycan biosynthetic process |
Biological Process | GO:0008543 | fibroblast growth factor receptor signaling pathway |
Biological Process | GO:0001711 | endodermal cell fate commitment |
Biological Process | GO:0061154 | endothelial tube morphogenesis |
Biological Process | GO:0042129 | regulation of T cell proliferation |
Biological Process | GO:0002052 | positive regulation of neuroblast proliferation |
Biological Process | GO:1990791 | dorsal root ganglion development |
Biological Process | GO:0030997 | regulation of centriole-centriole cohesion |
Biological Process | GO:0032212 | positive regulation of telomere maintenance via telomerase |
Biological Process | GO:0003338 | metanephros morphogenesis |
Biological Process | GO:0097091 | synaptic vesicle clustering |
Biological Process | GO:0060742 | epithelial cell differentiation involved in prostate gland development |
Biological Process | GO:0072053 | renal inner medulla development |
Biological Process | GO:0007405 | neuroblast proliferation |
Biological Process | GO:0010629 | negative regulation of gene expression |
Biological Process | GO:0048643 | positive regulation of skeletal muscle tissue development |
Biological Process | GO:0051450 | myoblast proliferation |
Biological Process | GO:0043525 | positive regulation of neuron apoptotic process |
Biological Process | GO:0060767 | epithelial cell proliferation involved in prostate gland development |
Biological Process | GO:0045453 | bone resorption |
Biological Process | GO:0032331 | negative regulation of chondrocyte differentiation |
Biological Process | GO:0045603 | positive regulation of endothelial cell differentiation |
Biological Process | GO:0045892 | negative regulation of DNA-templated transcription |
Biological Process | GO:0034333 | adherens junction assembly |
Biological Process | GO:0045671 | negative regulation of osteoclast differentiation |
Biological Process | GO:0060492 | lung induction |
Biological Process | GO:0002089 | lens morphogenesis in camera-type eye |
Biological Process | GO:2000017 | positive regulation of determination of dorsal identity |
Biological Process | GO:0043524 | negative regulation of neuron apoptotic process |
Biological Process | GO:0007249 | I-kappaB kinase/NF-kappaB signaling |
Biological Process | GO:0000165 | MAPK cascade |
Biological Process | GO:0060484 | lung-associated mesenchyme development |
Biological Process | GO:0007398 | ectoderm development |
Biological Process | GO:1904888 | cranial skeletal system development |
Biological Process | GO:1990138 | neuron projection extension |
Biological Process | GO:0001701 | in utero embryonic development |
Biological Process | GO:0001702 | gastrulation with mouth forming second |
Biological Process | GO:1990963 | establishment of blood-retinal barrier |
Biological Process | GO:0035050 | embryonic heart tube development |
Biological Process | GO:0010718 | positive regulation of epithelial to mesenchymal transition |
Biological Process | GO:0090090 | negative regulation of canonical Wnt signaling pathway |
Biological Process | GO:0048709 | oligodendrocyte differentiation |
Biological Process | GO:0043066 | negative regulation of apoptotic process |
Biological Process | GO:0001837 | epithelial to mesenchymal transition |
Biological Process | GO:0048489 | synaptic vesicle transport |
Biological Process | GO:0000578 | embryonic axis specification |
Biological Process | GO:0030316 | osteoclast differentiation |
Biological Process | GO:2000648 | positive regulation of stem cell proliferation |
Biological Process | GO:0009948 | anterior/posterior axis specification |
Biological Process | GO:0097190 | apoptotic signaling pathway |
Biological Process | GO:0033234 | negative regulation of protein sumoylation |
Biological Process | GO:0060789 | hair follicle placode formation |
Biological Process | GO:0072033 | renal vesicle formation |
Biological Process | GO:0001840 | neural plate development |
Biological Process | GO:0045893 | positive regulation of DNA-templated transcription |
Biological Process | GO:0048715 | negative regulation of oligodendrocyte differentiation |
Molecular Function | GO:0140297 | DNA-binding transcription factor binding |
Molecular Function | GO:0070411 | I-SMAD binding |
Molecular Function | GO:0061629 | RNA polymerase II-specific DNA-binding transcription factor binding |
Molecular Function | GO:0046332 | SMAD binding |
Molecular Function | GO:0045294 | alpha-catenin binding |
Molecular Function | GO:0045296 | cadherin binding |
Molecular Function | GO:0003682 | chromatin binding |
Molecular Function | GO:0097718 | disordered domain specific binding |
Molecular Function | GO:0019899 | enzyme binding |
Molecular Function | GO:1990226 | histone methyltransferase binding |
Molecular Function | GO:0019900 | kinase binding |
Molecular Function | GO:0030331 | nuclear estrogen receptor binding |
Molecular Function | GO:0016922 | nuclear receptor binding |
Molecular Function | GO:0019901 | protein kinase binding |
Molecular Function | GO:0019903 | protein phosphatase binding |
Molecular Function | GO:0003713 | transcription coactivator activity |
Molecular Function | GO:0001221 | transcription coregulator binding |
Molecular Function | GO:0001222 | transcription corepressor binding |
Molecular Function | GO:0044325 | transmembrane transporter binding |
Molecular Function | GO:0031625 | ubiquitin protein ligase binding |
Cellular Component | GO:0098685 | Schaffer collateral - CA1 synapse |
Cellular Component | GO:0034750 | Scrib-APC-beta-catenin complex |
Cellular Component | GO:1990909 | Wnt signalosome |
Cellular Component | GO:0030018 | Z disc |
Cellular Component | GO:0005912 | adherens junction |
Cellular Component | GO:0045177 | apical part of cell |
Cellular Component | GO:0016327 | apicolateral plasma membrane |
Cellular Component | GO:0016323 | basolateral plasma membrane |
Cellular Component | GO:0030877 | beta-catenin destruction complex |
Cellular Component | GO:1990711 | beta-catenin-ICAT complex |
Cellular Component | GO:1990907 | beta-catenin-TCF complex |
Cellular Component | GO:0070369 | beta-catenin-TCF7L2 complex |
Cellular Component | GO:0005923 | bicellular tight junction |
Cellular Component | GO:0016342 | catenin complex |
Cellular Component | GO:0005938 | cell cortex |
Cellular Component | GO:0030054 | cell junction |
Cellular Component | GO:0071944 | cell periphery |
Cellular Component | GO:0005911 | cell-cell junction |
Cellular Component | GO:0005813 | centrosome |
Cellular Component | GO:0005737 | cytoplasm |
Cellular Component | GO:0005829 | cytosol |
Cellular Component | GO:0000791 | euchromatin |
Cellular Component | GO:0070062 | extracellular exosome |
Cellular Component | GO:0005916 | fascia adherens |
Cellular Component | GO:0016600 | flotillin complex |
Cellular Component | GO:0005925 | focal adhesion |
Cellular Component | GO:0098978 | glutamatergic synapse |
Cellular Component | GO:0030027 | lamellipodium |
Cellular Component | GO:0016328 | lateral plasma membrane |
Cellular Component | GO:0016020 | membrane |
Cellular Component | GO:0031528 | microvillus membrane |
Cellular Component | GO:0005654 | nucleoplasm |
Cellular Component | GO:0005634 | nucleus |
Cellular Component | GO:0048471 | perinuclear region of cytoplasm |
Cellular Component | GO:0005886 | plasma membrane |
Cellular Component | GO:0099092 | postsynaptic density, intracellular component |
Cellular Component | GO:0045211 | postsynaptic membrane |
Cellular Component | GO:0098831 | presynaptic active zone cytoplasmic component |
Cellular Component | GO:0042734 | presynaptic membrane |
Cellular Component | GO:0032993 | protein-DNA complex |
Cellular Component | GO:0032991 | protein-containing complex |
Cellular Component | GO:0000922 | spindle pole |
Cellular Component | GO:0045202 | synapse |
Cellular Component | GO:0005667 | transcription regulator complex |
Reactome
|
Reactome Name | Node type
|
Reactome Root | Reactome Root Name |
---|---|---|---|---|
R-HSA-195253 | Degradation of beta-catenin by the destruction complex | Internal node | R-HSA-162582 | Signal Transduction |
R-HSA-196299 | Beta-catenin phosphorylation cascade | Leaf | R-HSA-162582 | Signal Transduction |
R-HSA-201681 | TCF dependent signaling in response to WNT | Internal node | R-HSA-162582 | Signal Transduction |
R-HSA-201722 | Formation of the beta-catenin:TCF transactivating complex | Internal node | R-HSA-162582 | Signal Transduction |
R-HSA-3134973 | LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | Leaf | R-HSA-168256 | Immune System |
R-HSA-351906 | Apoptotic cleavage of cell adhesion proteins | Leaf | R-HSA-5357801 | Programmed Cell Death |
R-HSA-3769402 | Deactivation of the beta-catenin transactivating complex | Leaf | R-HSA-162582 | Signal Transduction |
R-HSA-381771 | Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | Leaf | R-HSA-392499 | Metabolism of proteins |
R-HSA-4086398 | Ca2+ pathway | Leaf | R-HSA-162582 | Signal Transduction |
R-HSA-418990 | Adherens junctions interactions | Internal node | R-HSA-1500931 | Cell-Cell communication |
R-HSA-4411364 | Binding of TCF/LEF:CTNNB1 to target gene promoters | Leaf | R-HSA-162582 | Signal Transduction |
R-HSA-4641262 | Disassembly of the destruction complex and recruitment of AXIN to the membrane | Leaf | R-HSA-162582 | Signal Transduction |
R-HSA-5218920 | VEGFR2 mediated vascular permeability | Leaf | R-HSA-162582 | Signal Transduction |
R-HSA-525793 | Myogenesis | Leaf | R-HSA-1266738 | Developmental Biology |
R-HSA-5339716 | Signaling by GSK3beta mutants | Leaf | R-HSA-1643685 | Disease |
R-HSA-5358747 | CTNNB1 S33 mutants aren't phosphorylated | Leaf | R-HSA-1643685 | Disease |
R-HSA-5358749 | CTNNB1 S37 mutants aren't phosphorylated | Leaf | R-HSA-1643685 | Disease |
R-HSA-5358751 | CTNNB1 S45 mutants aren't phosphorylated | Leaf | R-HSA-1643685 | Disease |
R-HSA-5358752 | CTNNB1 T41 mutants aren't phosphorylated | Leaf | R-HSA-1643685 | Disease |
R-HSA-5626467 | RHO GTPases activate IQGAPs | Leaf | R-HSA-162582 | Signal Transduction |
R-HSA-8853884 | Transcriptional Regulation by VENTX | Leaf | R-HSA-74160 | Gene expression (Transcription) |
R-HSA-8876493 | InlA-mediated entry of Listeria monocytogenes into host cells | Leaf | R-HSA-1643685 | Disease |
R-HSA-8951430 | RUNX3 regulates WNT signaling | Leaf | R-HSA-74160 | Gene expression (Transcription) |
R-HSA-9754189 | Germ layer formation at gastrulation | Leaf | R-HSA-1266738 | Developmental Biology |
R-HSA-9793380 | Formation of paraxial mesoderm | Internal node | R-HSA-1266738 | Developmental Biology |
R-HSA-9796292 | Formation of axial mesoderm | Leaf | R-HSA-1266738 | Developmental Biology |
Location
|
ECO term
|
Pubmed |
---|---|---|
Cell junction | ECO:0000250 | |
Cell junction, adherens junction | ECO:0000269 | PubMed:10725230 |
Cell membrane | ECO:0000269 | PubMed:11790773 |
Cell membrane | ECO:0000269 | PubMed:24342833 |
Cytoplasm | ECO:0000269 | PubMed:25183871 |
Cytoplasm | ECO:0000269 | PubMed:29739711 |
Cytoplasm | ECO:0000269 | PubMed:31801859 |
Cytoplasm, cytoskeleton | ECO:0000250 | |
Cytoplasm, cytoskeleton, cilium basal body | ECO:0000250 | |
Cytoplasm, cytoskeleton, microtubule organizing center, centrosome | ||
Cytoplasm, cytoskeleton, spindle pole | ||
Nucleus | ECO:0000269 | PubMed:24342833 |
Nucleus | ECO:0000269 | PubMed:25183871 |
Nucleus | ECO:0000269 | PubMed:28829046 |
Nucleus | ECO:0000269 | PubMed:29367600 |
Nucleus | ECO:0000269 | PubMed:29739711 |
Nucleus | ECO:0000269 | PubMed:31801859 |
Synapse | ECO:0000250 |
HPO ID
|
HPO name |
---|---|
HP:0040049 | Macular edema |
HP:0002315 | Headache |
HP:0000568 | Microphthalmia |
HP:0004324 | Increased body weight |
HP:0025336 | Delayed ability to sit |
HP:0002637 | Cerebral ischemia |
HP:0001395 | Hepatic fibrosis |
HP:0000080 | Abnormality of reproductive system physiology |
HP:0410019 | Epigastric pain |
HP:0030242 | Portal vein thrombosis |
HP:0006254 | Elevated circulating alpha-fetoprotein concentration |
HP:0002024 | Malabsorption |
HP:0040075 | Hypopituitarism |
HP:0000006 | Autosomal dominant inheritance |
HP:0000430 | Underdeveloped nasal alae |
HP:0010766 | Ectopic calcification |
HP:0007924 | Slow decrease in visual acuity |
HP:0000711 | Restlessness |
HP:0100014 | Epiretinal membrane |
HP:0000737 | Irritability |
HP:0002516 | Increased intracranial pressure |
HP:0030666 | Retinal neovascularization |
HP:0003621 | Juvenile onset |
HP:0002719 | Recurrent infections |
HP:0012505 | Enlarged pituitary gland |
HP:0008052 | Retinal fold |
HP:0001376 | Limitation of joint mobility |
HP:0030496 | Macular exudate |
HP:0005214 | Intestinal obstruction |
HP:0003508 | Proportionate short stature |
HP:0031526 | Subretinal fluid |
HP:0008897 | Postnatal growth retardation |
HP:0007703 | Abnormality of retinal pigmentation |
HP:0001141 | Severely reduced visual acuity |
HP:0000739 | Anxiety |
HP:0007773 | Vitreoretinopathy |
HP:0002891 | Uterine leiomyosarcoma |
HP:0012288 | Neoplasm of head and neck |
HP:0006774 | Ovarian papillary adenocarcinoma |
HP:0002591 | Polyphagia |
HP:0025436 | Elevated serum 11-deoxycortisol |
HP:0000863 | Central diabetes insipidus |
HP:0004349 | Reduced bone mineral density |
HP:0030588 | Abnormal visual field test |
HP:0000822 | Hypertension |
HP:0100749 | Chest pain |
HP:0003396 | Syringomyelia |
HP:0002191 | Progressive spasticity |
HP:0000533 | Chorioretinal atrophy |
HP:0002079 | Hypoplasia of the corpus callosum |
HP:0001263 | Global developmental delay |
HP:0030348 | Increased circulating androgen concentration |
HP:0010576 | Intracranial cystic lesion |
HP:0002015 | Dysphagia |
HP:0001262 | Excessive daytime somnolence |
HP:0002376 | Developmental regression |
HP:0002239 | Gastrointestinal hemorrhage |
HP:0002900 | Hypokalemia |
HP:0001824 | Weight loss |
HP:0000486 | Strabismus |
HP:0002360 | Sleep disturbance |
HP:0002240 | Hepatomegaly |
HP:0003002 | Breast carcinoma |
HP:0010939 | Abnormal nasal bone morphology |
HP:0001500 | Broad finger |
HP:0004298 | Abnormality of the abdominal wall |
HP:0000545 | Myopia |
HP:0002144 | Tethered cord |
HP:0008936 | Axial hypotonia |
HP:0000252 | Microcephaly |
HP:0000540 | Hypermetropia |
HP:0100832 | Vitreous floaters |
HP:0010614 | Fibroma |
HP:0003011 | Abnormality of the musculature |
HP:0002188 | Delayed CNS myelination |
HP:0001493 | Falciform retinal fold |
HP:0007685 | Peripheral retinal avascularization |
HP:0000546 | Retinal degeneration |
HP:0000819 | Diabetes mellitus |
HP:0002321 | Vertigo |
HP:0011750 | Neoplasm of the anterior pituitary |
HP:0006740 | Transitional cell carcinoma of the bladder |
HP:0000639 | Nystagmus |
HP:0033559 | Anti-myeloperoxidase antibody positivity |
HP:0000007 | Autosomal recessive inheritance |
HP:0002013 | Vomiting |
HP:0030490 | Exudative vitreoretinopathy |
HP:0001413 | Micronodular cirrhosis |
HP:0012378 | Fatigue |
HP:0002514 | Cerebral calcification |
HP:0002650 | Scoliosis |
HP:0003110 | Abnormality of urine homeostasis |
HP:0000648 | Optic atrophy |
HP:0200008 | Intestinal polyposis |
HP:0001482 | Subcutaneous nodule |
HP:0000742 | Self-mutilation |
HP:0025269 | Panic attack |
HP:0012795 | Abnormal optic disc morphology |
HP:0000044 | Hypogonadotropic hypogonadism |
HP:0001249 | Intellectual disability |
HP:0001264 | Spastic diplegia |
HP:0006744 | Adrenocortical carcinoma |
HP:0003593 | Infantile onset |
HP:0002027 | Abdominal pain |
HP:0006753 | Neoplasm of the stomach |
HP:0011734 | Central adrenal insufficiency |
HP:0000518 | Cataract |
HP:0000365 | Hearing impairment |
HP:0000998 | Hypertrichosis |
HP:0030503 | Macular telangiectasia |
HP:0000455 | Broad nasal tip |
HP:0007917 | Tractional retinal detachment |
HP:0001065 | Striae distensae |
HP:0000718 | Aggressive behavior |
HP:0000541 | Retinal detachment |
HP:0009765 | Low hanging columella |
HP:0002605 | Hepatic necrosis |
HP:0030521 | Bitemporal hemianopia |
HP:0007987 | Progressive visual field defects |
HP:0002885 | Medulloblastoma |
HP:0000238 | Hydrocephalus |
HP:0001939 | Abnormality of metabolism/homeostasis |
HP:0000478 | Abnormality of the eye |
HP:0007902 | Vitreous hemorrhage |
HP:0000219 | Thin upper lip vermilion |
HP:0033128 | Delayed ability to crawl |
HP:0100245 | Desmoid tumors |
HP:0010535 | Sleep apnea |
HP:0000319 | Smooth philtrum |
HP:0001402 | Hepatocellular carcinoma |
HP:0010935 | Abnormality of the upper urinary tract |
HP:0001428 | Somatic mutation |
HP:0003466 | Paradoxical increased cortisol secretion on dexamethasone suppression test |
HP:0008245 | Pituitary hypothyroidism |
HP:0006716 | Hereditary nonpolyposis colorectal carcinoma |
HP:0100621 | Dysgerminoma |
HP:0001518 | Small for gestational age |
HP:0003118 | Increased circulating cortisol level |
HP:0000135 | Hypogonadism |
HP:0011451 | Primary microcephaly |
HP:0001658 | Myocardial infarction |
HP:0001270 | Motor delay |
HP:0030434 | Pilomatrixoma |
HP:0006572 | Subacute progressive viral hepatitis |
HP:0001252 | Hypotonia |
HP:0011968 | Feeding difficulties |
HP:0005584 | Renal cell carcinoma |
HP:0001085 | Papilledema |
HP:0100716 | Self-injurious behavior |
HP:0002829 | Arthralgia |
HP:0012230 | Rhegmatogenous retinal detachment |
HP:0003623 | Neonatal onset |
HP:0001117 | Sudden loss of visual acuity |
HP:0008069 | Neoplasm of the skin |
HP:0000708 | Atypical behavior |
HP:0000859 | Hyperaldosteronism |
HP:0001257 | Spasticity |
HP:0000975 | Hyperhidrosis |
HP:0002797 | Osteolysis |
HP:0001259 | Coma |
HP:0000218 | High palate |
HP:0001256 | Intellectual disability, mild |
HP:0002017 | Nausea and vomiting |
HP:0001510 | Growth delay |
HP:0500022 | Abnormal circulating dehydroepiandrosterone concentration |
HP:0011748 | Adrenocorticotropic hormone deficiency |
HP:0007663 | Reduced visual acuity |
HP:0025380 | Increased circulating androstenedione concentration |
HP:0025160 | Abnormal temper tantrums |
HP:0002465 | Poor speech |
HP:0000126 | Hydronephrosis |
HP:0012030 | Increased urinary cortisol level |
HP:0002659 | Increased susceptibility to fractures |
HP:0001962 | Palpitations |
HP:0100806 | Sepsis |
HP:0003326 | Myalgia |
HP:0012286 | Abnormal hypothalamus morphology |
HP:0005978 | Type II diabetes mellitus |
HP:0030078 | Lung adenocarcinoma |
HP:0000989 | Pruritus |
HP:0000870 | Increased circulating prolactin concentration |
HP:0000823 | Delayed puberty |
HP:0025134 | Increased serum estradiol |
HP:0031936 | Delayed ability to walk |
HP:0001004 | Lymphedema |
HP:0430000 | Abnormal frontal bone morphology |
HP:0002119 | Ventriculomegaly |
HP:0001250 | Seizure |
HP:0000729 | Autistic behavior |
HP:0011342 | Mild global developmental delay |
HP:0011530 | Retinal hole |
HP:0000343 | Long philtrum |
HP:0001513 | Obesity |
HP:0001324 | Muscle weakness |
HP:0003829 | Typified by incomplete penetrance |
HP:0001999 | Abnormal facial shape |
HP:0000618 | Blindness |
Disease name | MONDO ID
|
ICD10
|
ICD10 chapter
|
OMIM
|
Orphanet
|
---|---|---|---|---|---|
colorectal cancer | MONDO:0005575 | C18 | chapter2, Neoplasms | OMIM:114500 | Orphanet:466667 |
malignant mesothelioma | MONDO:0006292 | C45 | chapter2, Neoplasms | OMIM:156240 | Orphanet:50251 |
hepatocellular carcinoma | MONDO:0007256 | C22 | chapter2, Neoplasms | OMIM:114550 | Orphanet:88673 |
pilomatrixoma | MONDO:0007564 | C44 | chapter2, Neoplasms | OMIM:132600 | Orphanet:91414 |
desmoid tumor | MONDO:0007608 | D48 | chapter2, Neoplasms | OMIM:135290 | Orphanet:873 |
medulloblastoma | MONDO:0007959 | C71 | chapter2, Neoplasms | OMIM:155255 | Orphanet:616 |
ovarian cancer | MONDO:0008170 | C56 | chapter2, Neoplasms | OMIM:167000 | Orphanet:213500 |
severe intellectual disability-progressive spastic diplegia syndrome | MONDO:0014035 | G11 | chapter6, Diseases of the nervous system | OMIM:615075 | Orphanet:404473 |
craniopharyngioma | MONDO:0018907 | D44 | chapter2, Neoplasms | Orphanet:54595 | |
exudative vitreoretinopathy 7 | MONDO:0033123 | H35 | chapter7, Diseases of the eye and adnexa | OMIM:617572 |